Augurex Overview
- Year Founded
-
2007
- Status
-
Private
- Employees
-
21
- Latest Deal Type
-
Accelerator/Inc
- Latest Deal Amount
-
$5M
- Investors
-
5
Augurex General Information
Description
Developer of biomarker-based clinical diagnostics designed to improve patient outcomes in autoimmune diseases. The company develops novel diagnostic tests that use biomarkers to enable early and accurate diagnosis, prognosis, and ongoing management of inflammatory autoimmune conditions such as rheumatoid arthritis and axial spondyloarthritis, helping healthcare providers personalise treatment plans, improve patient outcomes, and reduce the burden of chronic disease.
Contact Information
Website
www.augurex.comCorporate Office
- 887 Great Northern Way
- Suite 220
- Vancouver, British Columbia V5T 4T5
- Canada
Corporate Office
- 887 Great Northern Way
- Suite 220
- Vancouver, British Columbia V5T 4T5
- Canada
Augurex Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Accelerator/Incubator | 14-Mar-2024 | $5M | Completed | Generating Revenue | ||
| 6. Later Stage VC | 25-Jan-2017 | Completed | Generating Revenue | |||
| 5. Angel (individual) | 01-Feb-2011 | Completed | Startup | |||
| 4. Angel (individual) | 01-May-2009 | Completed | Startup | |||
| 3. Angel (individual) | 01-Nov-2007 | Completed | Startup | |||
| 2. Grant | 01-Jan-2007 | $52.8K | Completed | Startup | ||
| 1. University Spin-Out | 01-Jan-2007 | Completed | Startup |
Augurex Comparisons
Industry
Financing
Details
Augurex Competitors (9)
One of Augurex’s 9 competitors is ONL Therapeutics, a Venture Capital-Backed company based in Ann Arbor, MI.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| ONL Therapeutics | Venture Capital-Backed | Ann Arbor, MI | ||||
| Adverum Biotechnologies | Formerly VC-backed | Redwood City, CA | ||||
| BioTissue (Biotechnology) | Venture Capital-Backed | Miami, FL | ||||
| Gradalis | Private Equity-Backed | Carrollton, TX | ||||
| Rein Therapeutics | Formerly VC-backed | Austin, TX |
Augurex Signals
Augurex Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Government of Canada | Limited Partner | |||
| Genome British Columbia | Not-For-Profit Venture Capital | Minority | ||
| WUTIF Capital | Angel Group | Minority | ||
| New Ventures BC | Accelerator/Incubator | |||
| The University of British Columbia | University |
Augurex FAQs
-
When was Augurex founded?
Augurex was founded in 2007.
-
Where is Augurex headquartered?
Augurex is headquartered in Vancouver, Canada.
-
What is the size of Augurex?
Augurex has 21 total employees.
-
What industry is Augurex in?
Augurex’s primary industry is Diagnostic Equipment.
-
Is Augurex a private or public company?
Augurex is a Private company.
-
What is Augurex’s current revenue?
The current revenue for Augurex is .
-
How much funding has Augurex raised over time?
Augurex has raised $5.12M.
-
Who are Augurex’s investors?
Government of Canada, Genome British Columbia, WUTIF Capital, New Ventures BC, and The University of British Columbia have invested in Augurex.
-
Who are Augurex’s competitors?
ONL Therapeutics, Adverum Biotechnologies, BioTissue (Biotechnology), Gradalis, and Rein Therapeutics are some of the 9 competitors of Augurex.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process